All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Steering CommitteeAbout UsNewsletterContact
Visit:
ALL HubAML HubGVhD HubMDS HubMPN HubMultiple Myeloma
Steering CommitteeAbout UsNewsletterContact
SubtypesTherapeuticsCongressesTrialsExpert Opinions
COSTEM 2021

Assoc. Prof. Constantine Tam | ICML 2017 | Ibrutinib + venetoclax in R/R MCL

By Anne Villeneuve
Featured
Constantine Tam
Jun 22, 2017
Share:

Ibrutinib + venetoclax in R/R MCL

Share:
More about...
IbrutinibICML 2017Mantle cell lymphomaMantle cell lymphomasVenetoclax

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox